Literature DB >> 18470926

Accelerator mass spectrometry.

Ragnar Hellborg1, Göran Skog.   

Abstract

In this overview the technique of accelerator mass spectrometry (AMS) and its use are described. AMS is a highly sensitive method of counting atoms. It is used to detect very low concentrations of natural isotopic abundances (typically in the range between 10(-12) and 10(-16)) of both radionuclides and stable nuclides. The main advantages of AMS compared to conventional radiometric methods are the use of smaller samples (mg and even sub-mg size) and shorter measuring times (less than 1 hr). The equipment used for AMS is almost exclusively based on the electrostatic tandem accelerator, although some of the newest systems are based on a slightly different principle. Dedicated accelerators as well as older "nuclear physics machines" can be found in the 80 or so AMS laboratories in existence today. The most widely used isotope studied with AMS is 14C. Besides radiocarbon dating this isotope is used in climate studies, biomedicine applications and many other fields. More than 100,000 14C samples are measured per year. Other isotopes studied include 10Be, 26Al, 36Cl, 41Ca, 59Ni, 129I, U, and Pu. Although these measurements are important, the number of samples of these other isotopes measured each year is estimated to be less than 10% of the number of 14C samples. Copyright 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18470926     DOI: 10.1002/mas.20172

Source DB:  PubMed          Journal:  Mass Spectrom Rev        ISSN: 0277-7037            Impact factor:   10.946


  10 in total

Review 1.  Accelerator mass spectrometry-enabled studies: current status and future prospects.

Authors:  Ali Arjomand
Journal:  Bioanalysis       Date:  2010-03       Impact factor: 2.681

2.  Development of 41Ca-based pharmacokinetic model for the study of bone remodelling in humans.

Authors:  Manju Sharma; Zeljko Bajzer; Susanta K Hui
Journal:  Clin Pharmacokinet       Date:  2011-03       Impact factor: 6.447

3.  Charge reversal Fourier transform ion cyclotron resonance mass spectrometry.

Authors:  Vladislav V Lobodin; Joshua J Savory; Nathan K Kaiser; Paul W Dunk; Alan G Marshall
Journal:  J Am Soc Mass Spectrom       Date:  2013-01-08       Impact factor: 3.109

4.  Quality of graphite target for biological/biomedical/environmental applications of 14C-accelerator mass spectrometry.

Authors:  Seung-Hyun Kim; Peter B Kelly; Volkan Ortalan; Nigel D Browning; Andrew J Clifford
Journal:  Anal Chem       Date:  2010-03-15       Impact factor: 6.986

5.  Calculating radiation exposures during use of (14)C-labeled nutrients, food components, and biopharmaceuticals to quantify metabolic behavior in humans.

Authors:  Seung-Hyun Kim; Peter B Kelly; Andrew J Clifford
Journal:  J Agric Food Chem       Date:  2010-04-28       Impact factor: 5.279

6.  Quantum-mechanical equilibrium isotopic fractionation correction to radiocarbon dating: a theory study.

Authors:  Jie Yuan; Yun Liu
Journal:  J Radioanal Nucl Chem       Date:  2011-12-16       Impact factor: 1.371

7.  Advances in structure elucidation of small molecules using mass spectrometry.

Authors:  Tobias Kind; Oliver Fiehn
Journal:  Bioanal Rev       Date:  2010-08-21

8.  Recirculation: A New Concept to Drive Innovation in Sustainable Product Design for Bio-Based Products.

Authors:  James Sherwood; James H Clark; Thomas J Farmer; Lorenzo Herrero-Davila; Laurianne Moity
Journal:  Molecules       Date:  2016-12-29       Impact factor: 4.411

9.  Accelerator mass spectrometry targets of submilligram carbonaceous samples using the high-throughput Zn reduction method.

Authors:  Seung-Hyun Kim; Peter B Kelly; Andrew J Clifford
Journal:  Anal Chem       Date:  2009-07-15       Impact factor: 6.986

Review 10.  In Vitro/In Vivo Toxicity Evaluation and Quantification of Iron Oxide Nanoparticles.

Authors:  Ujwal S Patil; Shiva Adireddy; Ashvin Jaiswal; Sree Mandava; Benjamin R Lee; Douglas B Chrisey
Journal:  Int J Mol Sci       Date:  2015-10-15       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.